Lp-PLA2与缺血性脑血管病患者脑动脉狭窄的关系被引量：4

The relationship between the Lipoprotein-associated phospholipase A2 and cerebral artery stenosis in patients with ischemic cerebrovascular disease

下载PDF

导出

摘要目的探讨缺血性脑血管病患者脂蛋白相关磷脂酶A2(lipoprotein-associated phospholipase A2,LpPLA2)与脑动脉狭窄的相互关系。方法应用荷兰飞利浦公司生产的FD-20 C型臂血管造影系统,对355例缺血性脑血管病患者进行全脑血管造影及血浆Lp-PLA2检测,Lp-PLA2正常组患者(对照组)151例与Lp-PLA2升高组(病例组)204例患者的全脑血管造影结果进行比较。结果对照组与病例组脑动脉狭窄程度差异有统计学意义(χ2=15.69,P<0.05);随着Lp-PLA2的升高,脑动脉狭窄程度逐渐加重。结论 Lp-PLA2是缺血性脑血管病脑动脉狭窄的一种危险因素,脑血管狭窄与Lp-PLA2升高有关,Lp-PLA2在一定程度上反应脑血管狭窄程度。 Objective To explore the relationship between lipoprotein-associated phospholipase A2（ Lp-PLA2） and cerebral artery stenosis of ischemic cerebrovascular patients. Methods Did cerebral angiography with FD-20 C-arm angiography system which produced by the Dutch company Philips and detected plasma of Lp-PLA2 among 355 patients who with ischemic cerebrovascular disease,compared cerebral angiography results between Lp-PLA2 normal group（ control group）and Lp-PLA2 increased group（ case group）. Results The cerebral artery stenosis between the control group and case group were statistically significant differences（ χ2= 15. 69,P〈0. 05）,along with the much increasing of Lp-PLA2,the more severe of cerebral artery stenosis. Conclusion Lp-PLA2 may be a risk factor of cerebral artery stenosis in ischemic cerebrovascular disease,cerebral vascular stenosis is related with Lp-PLA2,which can reflect the severity of cerebral artery stenosis to some extent.

作者石艳超杜大勇许航李元培孟虹媛王江川张东菊

机构地区天津港口医院神经内科

出处《中风与神经疾病杂志》 CAS 北大核心 2015年第8期699-701,共3页 Journal of Apoplexy and Nervous Diseases

关键词脑缺血脂蛋白相关磷脂酶A2 脑动脉狭窄 Cerebral ischemic Lp-PLA2 Cerebral artery stenosis

分类号 R743.3 [医药卫生—神经病学与精神病学]

引文网络
相关文献

参考文献9

1Devaraj S,Xu DJ,Jialal I.C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells:implications for the metabolic syndrome and atherothrombosis[J].Circulation,2003,107(1):398-404.
2Anderson JL.Lipoprotein-associated phospholipase A2:an independent predictor of coronary artery disease events in primary and secondary prevention[J].Am J Cardiol,2008,101(Suppl):23-33.
3Oei HHS,Van der Meer IM,Hofman A,el al.Lipoprotein-associated Phospholipase A2 is associated with risk of coronary heart disease and stroke[J].Circulation,2005,111:570-575.
4Rosenson RS,Vracar-Grabar M,Helenowski L.Lipeprotein associated phospholipase A2 inhibition reduces generation of oxidized fatty acids:Lp-LPA2 reduces oxidized fatty acids[J].Cardiovase Drugs Ther,2008,22(1):55-58.
5Khuseyinova N,Koenig W.Predicting the risk of cardiovascular disease[J].Mol Diagn Ther,2007,11(4):203-217.
6Epps KC,Wilensky RL.Lp-PLA2-a novel risk factor for highrisk coronary and carotid artery disease[J].J Intern Med,2011,269(1):94-106.
7Wassertheil-Smoller S,Kooperberg C,Mc Ginn AP,et al.Lipoproteinassociated phospholipase A2,hormone use,and the risk of ischemic stroke in postmenopausal women[J].Hypertension,2008,51(4):1115-1122.
8Persson M,Beglund G,Nelson J,et al.Lp-PLA2 activity and mass are associated with increased incidence of ischemic stroke[J].Atherosclerosis,2008,200(1):191-198.
9Massot A,Pelegri D,Penalba A,et al.Lipoprotein-associated phospholipase A2 testing usefulness among patients with symptomatic intracranial atherosclerotic disease[J].Atherosclerosis,2011,218(1):181-187.